Recently, I was lucky enough to meet with some of the best and brightest researchers in depression treatment. In addition to university-based researchers, there were some pharmaceutical representatives and a key leader from the FDA at the meeting. The conference was titled "Advancing Signal Strength in Proof of Concept Studies in Major Depression" and was sponsored by the University of Arizona's psychiatry department. Its focus was on advancing signal strength.
What does that mean? What's a...
